Loading insider details...
Beta
Latest Form 4 (Jun 13, 2024): Grant/Award of 800 EFTR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 13, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 800 | n/a |
| Feb 21, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 2,000 | n/a |
| Jun 22, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 20,000 | n/a |
| Jan 24, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 50,938 | n/a |
| Jun 27, 2022 | eFFECTOR Therapeutics, Inc. (EFTR) | Purchase | 30,000 | $47.7K |
| Jun 13, 2022 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 20,000 | n/a |
| Oct 8, 2021 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 40,000 | n/a |
| Aug 27, 2021 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 4,822,114 | n/a |